COMMUNIQUÉS West-GlobeNewswire

Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference

15/02/2018 - 14:00

MORRIS PLAINS, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will participate in [...]

Progressive Care to Accept Bitcoin for its Pharmacy Unit

15/02/2018 - 14:00

MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers [...]

Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congress

15/02/2018 - 14:00

SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today presented data from the U.S. 88 patient, 19 center, randomized, double blind, placebo-controlled [...]

Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018

15/02/2018 - 14:00

BRIDGEWATER, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will [...]

Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion

15/02/2018 - 14:00

TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Health Canada (HC) has approved [...]

Dr. Joseph DeSanto and BioCorRx Recovery Program Participant Appear on the TV Show, The Doctors

15/02/2018 - 14:00

ANAHEIM, CA, Feb. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Dr. [...]

Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conference

15/02/2018 - 14:00

EAST RUTHERFORD, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]

Capital Senior Living Named One of the Top Senior Living Providers in J.D. Power Resident Satisfaction Survey

15/02/2018 - 12:45

DALLAS, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, was recognized by J.D. Power, a global market [...]

RadNet, Inc. to Present at the RBC Capital Markets Healthcare Conference on February 21, 2018

15/02/2018 - 12:00

LOS ANGELES, Feb. 15, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Avid Bioservices Announces Pricing of Public Offering of Common Stock

15/02/2018 - 11:00

TUSTIN, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price [...]

Genetic Technologies Announces Strategic Alliance and Capital Raising

15/02/2018 - 11:00

MELBOURNE, Australia, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”, “ GTG ”) a molecular diagnostics company and provider of BREVAGen plus ®, a first-in-class, [...]

Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti™

15/02/2018 - 13:30

SOLANA BEACH, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced additional [...]

Shire plc : Director/PDMR Shareholding

15/02/2018 - 13:01

Director/PDMR Shareholding February 15, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging [...]

Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use

15/02/2018 - 13:00

Shire Announces FDA Acceptance of sBLA for CINRYZE ® (C1 esterase inhibitor [human]) for Pediatric Hereditary Angioedema Use FDA assigns an action date of June 20, 2018 If approved, CINRYZE will be the first and only C1 [...]

Tonix Pharmaceuticals Appoints David L. Grange to the Board of Directors

15/02/2018 - 13:00

NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix) today announced the appointment of David L. Grange, a retired U.S. Army Brigadier General, to the Board of [...]

Cutera Showcases Expanded Portfolio at AAD

15/02/2018 - 13:00

SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- AAD 2018 -- At the 2018 American Academy of Dermatology (AAD) Annual Conference, Cutera, Inc. (Nasdaq: CUTR ), (“Cutera” or the “Company”), is showcasing the recently [...]

Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization

15/02/2018 - 13:00

REDWOOD CITY, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director [...]

Protalix BioTherapeutics Announces Final Dosing of Last Patient in Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis

15/02/2018 - 13:00

CARMIEL, Israel, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), announced today the final dosing of the last patient in the Company’s phase II clinical trial [...]

Asterias Expands Global IP Portfolio with New Patents, Including Key Additional Patent Protection for its Cancer Immunotherapy Program

15/02/2018 - 13:00

FREMONT, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing regenerative medicine therapeutics to treat neurological conditions [...]